Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3402)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2023 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 [PMID: 37213403 DOI: 10.3748/wjg.v29.i17.2666] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i17/2666.htm |
| Number | Citing Articles |
| 1 |
Lukas Bethlehem, Maria Manuela Estevinho, Ari Grinspan, Fernando Magro, Jeremiah J Faith, Jean-Frederic Colombel. Microbiota therapeutics for inflammatory bowel disease: the way forward. The Lancet Gastroenterology & Hepatology 2024; 9(5): 476 doi: 10.1016/S2468-1253(23)00441-7
|
| 2 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2024; : gutjnl-2023-331550 doi: 10.1136/gutjnl-2023-331550
|
| 3 |
Xueyi Qian, Hua Jiang, Yao Wu, Huimin Shao, Weijie He, Yinmei He, Xin Bao, Lianjun He, Yuliang Jia, Zhenyu Xu. Fecal microbiota transplantation combined with prebiotics ameliorates ulcerative colitis in mice. Future Microbiology 2023; doi: 10.2217/fmb-2023-0001
|
| 4 |
Umang Arora, Saurabh Kedia, Vineet Ahuja. The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research 2024; 22(1): 44 doi: 10.5217/ir.2023.00085
|
| 5 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; doi: 10.1016/j.jhin.2024.03.001
|